Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
William Roland Mann currently holds 11,200 shares of NeuBase Therapeutics, Inc. (NBSE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, William Roland Mann has been a net buyer of NBSE stock. They have purchased $36.9K and sold $0 worth of shares.
William Roland Mann's most recent insider trade was on Mar 30, 2022, when they purchased 6,200 shares at $1.92 per share.
William Roland Mann serves as Executive at NeuBase Therapeutics, Inc. (NBSE). They have executed 2 insider transactions totaling $36.9K over their tenure at the company.
William Roland Mann holds the position of Executive at NeuBase Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
William Roland Mann has shown a buying trading pattern, with $36.9K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by William Roland Mann was on Apr 26, 2021, when they purchased $25.0K worth of NBSE shares. This transaction involved 5,000 shares at $5.00 per share.
William Roland Mann currently owns 11,200 shares of NeuBase Therapeutics, Inc. (NBSE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of William Roland Mann's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. William Roland Mann has 2 Form 4 filings on record as an insider at NeuBase Therapeutics, Inc..
Set alerts for William Roland Mann and 40,000+ other insiders.